@article{a4f18e9caf9d4ab38f80ab20f0b9ece4,
title = "Update on treatment strategies for vasculitis affecting the central nervous system.",
keywords = "GIANT-CELL ARTERITIS, PRIMARY ANGIITIS, TAKAYASU ARTERITIS, MANAGEMENT, RITUXIMAB, THERAPY, RECOMMENDATIONS, BLOCKADE, EFFICACY",
author = "Constantin Hecker and Tobias Welponer and Manfred Herold and Eugen Trinka and Erasmia Broussalis and Monika Killer-Oberpfalzer",
note = "Hecker; Broussalis; Killer-Oberpfalzer: Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria; Department of Neurology, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Paracelsus Medical University Salzburg, Salzburg, Austria; Welponer: Department of Dermatology and Allergology, Paracelsus Medical University Salzburg, Salzburg, Austria; Herold: Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology, and Rheumatology, Paracelsus Medical University Salzburg, Salzburg, Austria; Trinka: Institute of Neurointervention, Paracelsus Medical University, Salzburg, Austria; Department of Neurology, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Paracelsus Medical University Salzburg, Salzburg, Austria; Neuroscience Institute, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Paracelsus Medical University Salzburg, Salzburg, Austria",
year = "2022",
doi = "10.1016/j.drudis.2021.11.020",
language = "English",
volume = "27",
pages = "1142--1155",
journal = "DRUG DISCOVERY TODAY",
issn = "1359-6446",
publisher = "Elsevier ",
number = "4",
}